Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drotrecogin Alfa (Activated) in Adult Patients with Septic Shock
2007-005441-38Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of drotrecogin alfa in septic shock, sponsored by Eli Lilly and Company. Started Nov 2007; status: completed.
02
Drugs
drotrecogin alfa
03
Conditions
septic shock
Beyond the preview
Go deeper on 2007-005441-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005441-38.